EY Biotech Report features the BioLabs Heidelberg Project as a promising translational approach.

fightCOVID@Heidelberg: an initiative across institution boundaries and disciplines

Innovation during Covid-19 pandemic

‘CELIS – Cluster Excellence in Life Sciences’ provides financial support for international exchanges

The Launch of the Rhine-Main-Neckar Directory, a new Guide to the region!

AbbVie successfully opening the BioRN Lounge Series in 2020

Time to review past achievements and planning next steps at BioRN Members’ Assembly

Artificial Intelligence: Applications and promises for healthcare at BioRN Annual Conference 2019

The complex art of translating discovery into therapy – an international perspective

BioRN Lounge: how "Open Targets" can transform drug discovery

Compliance: a regulatory obstacle or an opportunity for your business?

BioRN Lounge: BioTech, MedTech and Digital Health startups from the European Health Catapult.

BioRN Lounge: A closed loop process for the treatment of oligometastatic patients at Research Campus

A Novel Format to Foster Innovation – the AbbVie Partnering Day

How to fill the Funding and Know-How Gap of the “Valley of Death”

BioRN Lounge: Innovation in an Increasingly Regulated Medical Device Environment.

Learning from the best part 2: Nurturing the BioRN regional startup ecosystem.

Learning from the best: how to accelerate academic research to the clinic.

Working together towards new objectives and activities in the Life Science Rhine/Main/Neckar Region.

BioRN Lounge: ATACs strategy to fight cancer at Heidelberg Pharma.